Upper stage problem slips Artemis II launch to April

NASA will roll the Space Launch System (SLS) 4 miles back to the Vehicle Assembly Building on or around Feb. 25 to troubleshoot a disrupted helium flow in the rocket's upper stage that cannot be accessed on the pad; the rollback is expected to take about 12 hours and will allow technicians to install movable platforms to reach the affected area. Last week's wet dress rehearsal largely resolved prior hydrogen leak issues and exercised countdown procedures, but the upper-stage helium problem removes March 6–9 and March 11 launch windows from contention, pushing the next available opportunities to April 1, April 3–6 and April 30; astronauts remain in Houston and NASA plans a media briefing this week.

Analysis

Market structure: The SLS rollback is a localized schedule shock benefiting ground-support and test-services contractors (KBR, Jacobs/KBR:KBR) and specialty propulsion suppliers (Aerojet Rocketdyne AJRD, Northrop Grumman NOC) who will pick up troubleshooting/change-order work; large OEMs (Boeing BA) face reputational and program-timing risk but limited near-term revenue hit given fixed-fee contracts. Expect a reallocation of near-term cash flows (weeks–months) to integration/repair vendors; pricing power for specialist crews/platform rentals can rise 5–15% on short notice in the Cape market for the next 30–90 days.

Risk assessment: Tail risks include a major hardware rework that pushes launch beyond April (probability ~10–15%), triggering multi-month revenue deferrals and potential contract penalties; regulatory/GAO scrutiny could follow if slips persist. Immediate risk window is 0–30 days while rollback and access occur; if launch slips past May 15, treat as a structural program delay with high-impact implications for suppliers over 3–12 months.

Trade implications: Tactical longs should target mid-cap suppliers with direct SLS exposure (AJRD, NOC) sized 1–3% of portfolio for potential 10–20% re-rating on near-term billable work; hedge with 1–2% notional 3-month BA puts (10% OTM) to protect against reputational spillover. Volatility trade: buy 3–6 month AJRD calls (15% OTM) or call spreads to capture repair-driven news spikes while limiting premium outlay.

Contrarian angles: Consensus will underweight space/specialty suppliers as “program-risk” assets — that’s likely overdone if the rollback is resolved within 4–6 weeks; mispricing window is short. If NASA announces a replacement launch window ≤April 30, expect a 5–12% bounce in exposed contractors; conversely, a new date >May 15 should trigger revisits and stop-losses.

Key Decisions for Investors

• Establish a 1.5% portfolio long in Aerojet Rocketdyne (AJRD) via stock or buy-write: allocate to AJRD for 3–6 months targeting a 10–20% upside on change-order revenue; set trailing stop at -8% and take-profit at +15%.
• Add a 1–2% long in Northrop Grumman (NOC) exposure (buy shares or 6-month 5% ITM calls) to capture integration/upper-stage work; exit or re-evaluate if NASA sets a new launch date beyond May 15.
• Purchase 1% notional hedge: Boeing (BA) 3-month puts 10% OTM (size to cost ~1% portfolio premium) to protect against reputational/spillover risk if program delays widen; close if BA implied vol rises >40% or after a confirmed April launch window.
• Implement volatility-defined option play: buy AJRD 3–6 month call spreads (15%/30% OTM) sized to 0.5–1% portfolio to capture event-driven gamma; roll or cut if no positive news within 60 days.
• Rotate tactically into defense/space suppliers (NOC, AJRD, KBR) overweight by +200 bps vs. benchmark for 1–3 months, funded by reducing commercial airline OEM exposure (BA, LUV) by -150–200 bps until launch date is reconfirmed.